Health
FDA approves HYMPAVZI for hemophilia patients
FDA approves HYMPAVZI for two additional hemophilia A or B patient populations, addressing significant unmet medical nee…
Marcus Rivera·
3 articles
FDA approves HYMPAVZI for two additional hemophilia A or B patient populations, addressing significant unmet medical nee…
US FDA approves Pfizer, Arvinas’ breast cancer drug on May 2, 2026, offering new hope and a significant advancement in o…
Pfizer is seeking FDA approval for a new Lyme disease vaccine, a landmark development that could transform public health…